MBX (MBX Biosciences, Inc.) operates in the Health technology sector. It's currently trading at $62.00. Our composite momentum score rates it 60/110 based on price +3.7% (1d), rsi 70.4 — overbought, roc9 +34.6% — sharp acceleration, macd 1.67 — strong bullish crossover, beta 1.95 — high beta, and analyst: strong buy. Up 49.1% across 3 tracked price points, from Jul 7, 2026 to Jul 8, 2026.